Global Imatinib Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
According to our (Global Info Research) latest study, the global Imatinib Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report is a detailed and comprehensive analysis for global Imatinib Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Imatinib Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Imatinib Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Imatinib Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics and Dr. Reddy's Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Imatinib Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Imatinib Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Imatinib Drug, with price, sales, revenue and global market share of Imatinib Drug from 2018 to 2023.
Chapter 3, the Imatinib Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imatinib Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Imatinib Drug.
Chapter 14 and 15, to describe Imatinib Drug sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Imatinib Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
This report is a detailed and comprehensive analysis for global Imatinib Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Imatinib Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Imatinib Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Imatinib Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Imatinib Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics and Dr. Reddy's Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Imatinib Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Tablets
- Capsules
- Chronic Myelogenous Leukemia
- Gastrointestinal Stromal Tumors
- Others
- Novartis
- Glenmark Pharmaceuticals Ltd.
- Sun Pharmaceuticals
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Cipla Inc.
- Apotex Inc.
- Mylan Pharms Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Imatinib Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Imatinib Drug, with price, sales, revenue and global market share of Imatinib Drug from 2018 to 2023.
Chapter 3, the Imatinib Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imatinib Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Imatinib Drug.
Chapter 14 and 15, to describe Imatinib Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Imatinib Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Imatinib Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablets
1.3.3 Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Imatinib Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Chronic Myelogenous Leukemia
1.4.3 Gastrointestinal Stromal Tumors
1.4.4 Others
1.5 Global Imatinib Drug Market Size & Forecast
1.5.1 Global Imatinib Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Imatinib Drug Sales Quantity (2018-2029)
1.5.3 Global Imatinib Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Imatinib Drug Product and Services
2.1.4 Novartis Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Glenmark Pharmaceuticals Ltd. Details
2.2.2 Glenmark Pharmaceuticals Ltd. Major Business
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
2.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business
2.3.3 Sun Pharmaceuticals Imatinib Drug Product and Services
2.3.4 Sun Pharmaceuticals Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sun Pharmaceuticals Recent Developments/Updates
2.4 Actavis Generics
2.4.1 Actavis Generics Details
2.4.2 Actavis Generics Major Business
2.4.3 Actavis Generics Imatinib Drug Product and Services
2.4.4 Actavis Generics Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Actavis Generics Recent Developments/Updates
2.5 Dr. Reddy's Laboratories
2.5.1 Dr. Reddy's Laboratories Details
2.5.2 Dr. Reddy's Laboratories Major Business
2.5.3 Dr. Reddy's Laboratories Imatinib Drug Product and Services
2.5.4 Dr. Reddy's Laboratories Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 Sanofi S.A.
2.7.1 Sanofi S.A. Details
2.7.2 Sanofi S.A. Major Business
2.7.3 Sanofi S.A. Imatinib Drug Product and Services
2.7.4 Sanofi S.A. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi S.A. Recent Developments/Updates
2.8 Cipla Inc.
2.8.1 Cipla Inc. Details
2.8.2 Cipla Inc. Major Business
2.8.3 Cipla Inc. Imatinib Drug Product and Services
2.8.4 Cipla Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cipla Inc. Recent Developments/Updates
2.9 Apotex Inc.
2.9.1 Apotex Inc. Details
2.9.2 Apotex Inc. Major Business
2.9.3 Apotex Inc. Imatinib Drug Product and Services
2.9.4 Apotex Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Apotex Inc. Recent Developments/Updates
2.10 Mylan Pharms Inc.
2.10.1 Mylan Pharms Inc. Details
2.10.2 Mylan Pharms Inc. Major Business
2.10.3 Mylan Pharms Inc. Imatinib Drug Product and Services
2.10.4 Mylan Pharms Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Pharms Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMATINIB DRUG BY MANUFACTURER
3.1 Global Imatinib Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Imatinib Drug Revenue by Manufacturer (2018-2023)
3.3 Global Imatinib Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Imatinib Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Imatinib Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Imatinib Drug Manufacturer Market Share in 2022
3.5 Imatinib Drug Market: Overall Company Footprint Analysis
3.5.1 Imatinib Drug Market: Region Footprint
3.5.2 Imatinib Drug Market: Company Product Type Footprint
3.5.3 Imatinib Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Imatinib Drug Market Size by Region
4.1.1 Global Imatinib Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Imatinib Drug Consumption Value by Region (2018-2029)
4.1.3 Global Imatinib Drug Average Price by Region (2018-2029)
4.2 North America Imatinib Drug Consumption Value (2018-2029)
4.3 Europe Imatinib Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Imatinib Drug Consumption Value (2018-2029)
4.5 South America Imatinib Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Imatinib Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Imatinib Drug Sales Quantity by Type (2018-2029)
5.2 Global Imatinib Drug Consumption Value by Type (2018-2029)
5.3 Global Imatinib Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Imatinib Drug Sales Quantity by Application (2018-2029)
6.2 Global Imatinib Drug Consumption Value by Application (2018-2029)
6.3 Global Imatinib Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Imatinib Drug Sales Quantity by Type (2018-2029)
7.2 North America Imatinib Drug Sales Quantity by Application (2018-2029)
7.3 North America Imatinib Drug Market Size by Country
7.3.1 North America Imatinib Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Imatinib Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Imatinib Drug Sales Quantity by Type (2018-2029)
8.2 Europe Imatinib Drug Sales Quantity by Application (2018-2029)
8.3 Europe Imatinib Drug Market Size by Country
8.3.1 Europe Imatinib Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Imatinib Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Imatinib Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Imatinib Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Imatinib Drug Market Size by Region
9.3.1 Asia-Pacific Imatinib Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Imatinib Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Imatinib Drug Sales Quantity by Type (2018-2029)
10.2 South America Imatinib Drug Sales Quantity by Application (2018-2029)
10.3 South America Imatinib Drug Market Size by Country
10.3.1 South America Imatinib Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Imatinib Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Imatinib Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Imatinib Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Imatinib Drug Market Size by Country
11.3.1 Middle East & Africa Imatinib Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Imatinib Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Imatinib Drug Market Drivers
12.2 Imatinib Drug Market Restraints
12.3 Imatinib Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Imatinib Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Imatinib Drug
13.3 Imatinib Drug Production Process
13.4 Imatinib Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Imatinib Drug Typical Distributors
14.3 Imatinib Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Imatinib Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Imatinib Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablets
1.3.3 Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Imatinib Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Chronic Myelogenous Leukemia
1.4.3 Gastrointestinal Stromal Tumors
1.4.4 Others
1.5 Global Imatinib Drug Market Size & Forecast
1.5.1 Global Imatinib Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Imatinib Drug Sales Quantity (2018-2029)
1.5.3 Global Imatinib Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Imatinib Drug Product and Services
2.1.4 Novartis Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Glenmark Pharmaceuticals Ltd. Details
2.2.2 Glenmark Pharmaceuticals Ltd. Major Business
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
2.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
2.3 Sun Pharmaceuticals
2.3.1 Sun Pharmaceuticals Details
2.3.2 Sun Pharmaceuticals Major Business
2.3.3 Sun Pharmaceuticals Imatinib Drug Product and Services
2.3.4 Sun Pharmaceuticals Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sun Pharmaceuticals Recent Developments/Updates
2.4 Actavis Generics
2.4.1 Actavis Generics Details
2.4.2 Actavis Generics Major Business
2.4.3 Actavis Generics Imatinib Drug Product and Services
2.4.4 Actavis Generics Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Actavis Generics Recent Developments/Updates
2.5 Dr. Reddy's Laboratories
2.5.1 Dr. Reddy's Laboratories Details
2.5.2 Dr. Reddy's Laboratories Major Business
2.5.3 Dr. Reddy's Laboratories Imatinib Drug Product and Services
2.5.4 Dr. Reddy's Laboratories Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 Sanofi S.A.
2.7.1 Sanofi S.A. Details
2.7.2 Sanofi S.A. Major Business
2.7.3 Sanofi S.A. Imatinib Drug Product and Services
2.7.4 Sanofi S.A. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi S.A. Recent Developments/Updates
2.8 Cipla Inc.
2.8.1 Cipla Inc. Details
2.8.2 Cipla Inc. Major Business
2.8.3 Cipla Inc. Imatinib Drug Product and Services
2.8.4 Cipla Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cipla Inc. Recent Developments/Updates
2.9 Apotex Inc.
2.9.1 Apotex Inc. Details
2.9.2 Apotex Inc. Major Business
2.9.3 Apotex Inc. Imatinib Drug Product and Services
2.9.4 Apotex Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Apotex Inc. Recent Developments/Updates
2.10 Mylan Pharms Inc.
2.10.1 Mylan Pharms Inc. Details
2.10.2 Mylan Pharms Inc. Major Business
2.10.3 Mylan Pharms Inc. Imatinib Drug Product and Services
2.10.4 Mylan Pharms Inc. Imatinib Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Pharms Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMATINIB DRUG BY MANUFACTURER
3.1 Global Imatinib Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Imatinib Drug Revenue by Manufacturer (2018-2023)
3.3 Global Imatinib Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Imatinib Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Imatinib Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Imatinib Drug Manufacturer Market Share in 2022
3.5 Imatinib Drug Market: Overall Company Footprint Analysis
3.5.1 Imatinib Drug Market: Region Footprint
3.5.2 Imatinib Drug Market: Company Product Type Footprint
3.5.3 Imatinib Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Imatinib Drug Market Size by Region
4.1.1 Global Imatinib Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Imatinib Drug Consumption Value by Region (2018-2029)
4.1.3 Global Imatinib Drug Average Price by Region (2018-2029)
4.2 North America Imatinib Drug Consumption Value (2018-2029)
4.3 Europe Imatinib Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Imatinib Drug Consumption Value (2018-2029)
4.5 South America Imatinib Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Imatinib Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Imatinib Drug Sales Quantity by Type (2018-2029)
5.2 Global Imatinib Drug Consumption Value by Type (2018-2029)
5.3 Global Imatinib Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Imatinib Drug Sales Quantity by Application (2018-2029)
6.2 Global Imatinib Drug Consumption Value by Application (2018-2029)
6.3 Global Imatinib Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Imatinib Drug Sales Quantity by Type (2018-2029)
7.2 North America Imatinib Drug Sales Quantity by Application (2018-2029)
7.3 North America Imatinib Drug Market Size by Country
7.3.1 North America Imatinib Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Imatinib Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Imatinib Drug Sales Quantity by Type (2018-2029)
8.2 Europe Imatinib Drug Sales Quantity by Application (2018-2029)
8.3 Europe Imatinib Drug Market Size by Country
8.3.1 Europe Imatinib Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Imatinib Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Imatinib Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Imatinib Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Imatinib Drug Market Size by Region
9.3.1 Asia-Pacific Imatinib Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Imatinib Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Imatinib Drug Sales Quantity by Type (2018-2029)
10.2 South America Imatinib Drug Sales Quantity by Application (2018-2029)
10.3 South America Imatinib Drug Market Size by Country
10.3.1 South America Imatinib Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Imatinib Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Imatinib Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Imatinib Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Imatinib Drug Market Size by Country
11.3.1 Middle East & Africa Imatinib Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Imatinib Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Imatinib Drug Market Drivers
12.2 Imatinib Drug Market Restraints
12.3 Imatinib Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Imatinib Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Imatinib Drug
13.3 Imatinib Drug Production Process
13.4 Imatinib Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Imatinib Drug Typical Distributors
14.3 Imatinib Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Imatinib Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Imatinib Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Imatinib Drug Product and Services
Table 6. Novartis Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Glenmark Pharmaceuticals Ltd. Major Business
Table 10. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 11. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 13. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceuticals Major Business
Table 15. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 16. Sun Pharmaceuticals Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sun Pharmaceuticals Recent Developments/Updates
Table 18. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 19. Actavis Generics Major Business
Table 20. Actavis Generics Imatinib Drug Product and Services
Table 21. Actavis Generics Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Actavis Generics Recent Developments/Updates
Table 23. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Reddy's Laboratories Major Business
Table 25. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 26. Dr. Reddy's Laboratories Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Dr. Reddy's Laboratories Recent Developments/Updates
Table 28. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Industries Ltd. Major Business
Table 30. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 31. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi S.A. Major Business
Table 35. Sanofi S.A. Imatinib Drug Product and Services
Table 36. Sanofi S.A. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi S.A. Recent Developments/Updates
Table 38. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Cipla Inc. Major Business
Table 40. Cipla Inc. Imatinib Drug Product and Services
Table 41. Cipla Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Cipla Inc. Recent Developments/Updates
Table 43. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Inc. Major Business
Table 45. Apotex Inc. Imatinib Drug Product and Services
Table 46. Apotex Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Apotex Inc. Recent Developments/Updates
Table 48. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Pharms Inc. Major Business
Table 50. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 51. Mylan Pharms Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan Pharms Inc. Recent Developments/Updates
Table 53. Global Imatinib Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Imatinib Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Imatinib Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Imatinib Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Imatinib Drug Production Site of Key Manufacturer
Table 58. Imatinib Drug Market: Company Product Type Footprint
Table 59. Imatinib Drug Market: Company Product Application Footprint
Table 60. Imatinib Drug New Market Entrants and Barriers to Market Entry
Table 61. Imatinib Drug Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Imatinib Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Imatinib Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Imatinib Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Imatinib Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Imatinib Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Imatinib Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Imatinib Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Imatinib Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Imatinib Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Imatinib Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Imatinib Drug Raw Material
Table 121. Key Manufacturers of Imatinib Drug Raw Materials
Table 122. Imatinib Drug Typical Distributors
Table 123. Imatinib Drug Typical Customers
Table 1. Global Imatinib Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Imatinib Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Imatinib Drug Product and Services
Table 6. Novartis Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Glenmark Pharmaceuticals Ltd. Major Business
Table 10. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 11. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
Table 13. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceuticals Major Business
Table 15. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 16. Sun Pharmaceuticals Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sun Pharmaceuticals Recent Developments/Updates
Table 18. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 19. Actavis Generics Major Business
Table 20. Actavis Generics Imatinib Drug Product and Services
Table 21. Actavis Generics Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Actavis Generics Recent Developments/Updates
Table 23. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Reddy's Laboratories Major Business
Table 25. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 26. Dr. Reddy's Laboratories Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Dr. Reddy's Laboratories Recent Developments/Updates
Table 28. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Industries Ltd. Major Business
Table 30. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 31. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi S.A. Major Business
Table 35. Sanofi S.A. Imatinib Drug Product and Services
Table 36. Sanofi S.A. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi S.A. Recent Developments/Updates
Table 38. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Cipla Inc. Major Business
Table 40. Cipla Inc. Imatinib Drug Product and Services
Table 41. Cipla Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Cipla Inc. Recent Developments/Updates
Table 43. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Apotex Inc. Major Business
Table 45. Apotex Inc. Imatinib Drug Product and Services
Table 46. Apotex Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Apotex Inc. Recent Developments/Updates
Table 48. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Pharms Inc. Major Business
Table 50. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 51. Mylan Pharms Inc. Imatinib Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan Pharms Inc. Recent Developments/Updates
Table 53. Global Imatinib Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Imatinib Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Imatinib Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Imatinib Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Imatinib Drug Production Site of Key Manufacturer
Table 58. Imatinib Drug Market: Company Product Type Footprint
Table 59. Imatinib Drug Market: Company Product Application Footprint
Table 60. Imatinib Drug New Market Entrants and Barriers to Market Entry
Table 61. Imatinib Drug Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Imatinib Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Imatinib Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Imatinib Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Imatinib Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Imatinib Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Imatinib Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Imatinib Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Imatinib Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Imatinib Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Imatinib Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Imatinib Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Imatinib Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Imatinib Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Imatinib Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Imatinib Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Imatinib Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Imatinib Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Imatinib Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Imatinib Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Imatinib Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Imatinib Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Imatinib Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Imatinib Drug Raw Material
Table 121. Key Manufacturers of Imatinib Drug Raw Materials
Table 122. Imatinib Drug Typical Distributors
Table 123. Imatinib Drug Typical Customers
LIST OF FIGURES
Figure 1. Imatinib Drug Picture
Figure 2. Global Imatinib Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Imatinib Drug Consumption Value Market Share by Type in 2022
Figure 4. Tablets Examples
Figure 5. Capsules Examples
Figure 6. Global Imatinib Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Imatinib Drug Consumption Value Market Share by Application in 2022
Figure 8. Chronic Myelogenous Leukemia Examples
Figure 9. Gastrointestinal Stromal Tumors Examples
Figure 10. Others Examples
Figure 11. Global Imatinib Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Imatinib Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Imatinib Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Imatinib Drug Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Imatinib Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Imatinib Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Imatinib Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Imatinib Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Imatinib Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Imatinib Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Imatinib Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Imatinib Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Imatinib Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Imatinib Drug Market Drivers
Figure 74. Imatinib Drug Market Restraints
Figure 75. Imatinib Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Imatinib Drug in 2022
Figure 78. Manufacturing Process Analysis of Imatinib Drug
Figure 79. Imatinib Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Imatinib Drug Picture
Figure 2. Global Imatinib Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Imatinib Drug Consumption Value Market Share by Type in 2022
Figure 4. Tablets Examples
Figure 5. Capsules Examples
Figure 6. Global Imatinib Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Imatinib Drug Consumption Value Market Share by Application in 2022
Figure 8. Chronic Myelogenous Leukemia Examples
Figure 9. Gastrointestinal Stromal Tumors Examples
Figure 10. Others Examples
Figure 11. Global Imatinib Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Imatinib Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Imatinib Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Imatinib Drug Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Imatinib Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Imatinib Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Imatinib Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Imatinib Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Imatinib Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Imatinib Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Imatinib Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Imatinib Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Imatinib Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Imatinib Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Imatinib Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Imatinib Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Imatinib Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Imatinib Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Imatinib Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Imatinib Drug Market Drivers
Figure 74. Imatinib Drug Market Restraints
Figure 75. Imatinib Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Imatinib Drug in 2022
Figure 78. Manufacturing Process Analysis of Imatinib Drug
Figure 79. Imatinib Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
